Key Takeaways
- • Peppermint, an AI-powered financial operations platform based in San Francisco, raised $4.7 million in seed funding, led by Moxxie.
- • Participating investors include Homebrew, Better Tomorrow Ventures, Layout Ventures, Digital Health Venture Partners, and Night Capital, along with angel investors Benjamin Mann and Evan Moore.
- • The company targets clinical research teams, aiming to streamline financial operations and support their growth.
- • The founding team previously built payments and reconciliation infrastructure at Robinhood, a credential that bears directly on the company's financial-infrastructure positioning.
Summary
Peppermint, an AI-powered platform headquartered in San Francisco, has announced $4.7 million in seed funding led by Moxxie. The round also included participation from Homebrew, Better Tomorrow Ventures, Layout Ventures, Digital Health Venture Partners, and Night Capital, as well as angel investors Benjamin Mann and Evan Moore.
The company positions its product as a platform that streamlines financial operations and accelerates growth for clinical research teams. Clinical research organizations often manage complex, multi-party financial workflows, and Peppermint's stated focus is on bringing automation to those processes, according to the company's announcement.
The founding team previously built payments and reconciliation infrastructure for Robinhood. The company says the new capital will allow the team to develop clinical research into what it describes as a scalable engine for financial growth and scientific discovery. The announcement did not disclose valuation, revenue, customer count, or a timeline for product expansion.
The seed round's investor syndicate spans venture firms with both fintech and digital health focus areas, including Digital Health Venture Partners, which suggests interest in the intersection of healthcare operations and financial software. Details beyond the original announcement were not available in the supplied material.
The company positions its product as a platform that streamlines financial operations and accelerates growth for clinical research teams. Clinical research organizations often manage complex, multi-party financial workflows, and Peppermint's stated focus is on bringing automation to those processes, according to the company's announcement.
The founding team previously built payments and reconciliation infrastructure for Robinhood. The company says the new capital will allow the team to develop clinical research into what it describes as a scalable engine for financial growth and scientific discovery. The announcement did not disclose valuation, revenue, customer count, or a timeline for product expansion.
The seed round's investor syndicate spans venture firms with both fintech and digital health focus areas, including Digital Health Venture Partners, which suggests interest in the intersection of healthcare operations and financial software. Details beyond the original announcement were not available in the supplied material.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.